The Deubiquitinating Enzyme UCHL1 Promotes Radiotherapy Resistance in Glioma by Stabilizing Keratin 18
International Journal of Molecular Sciences · 04.11.2026 · 27 (21) · 9875
DOI: 10.3390/ijms27219875 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.11.2026. Verfasst von Hanlu Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Children's Hospital of Soochow University, Suzhou 215025, China. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Radiation Tolerance, Glioma, Brain Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Suzhou Municipal Health Commission, Jiangsu Province Key Laboratory of Anesthesiology.
Abstract (Originalsprache)
Maintaining stemness in glioma stem cells (GSCs), coupled with robust DNA damage repair capacity, is a key determinant of radioresistance in glioma. Although the deubiquitinating enzyme ubiquitin carboxy-terminal hydrolase L1 (UCHL1) has been implicated in regulating tumor cell functions and facilitating malignant progression, its specific role in sustaining GSC stemness and in promoting radioresistance remains poorly understood. In this study, we combined secondary analyses of public datasets with in–house experimental investigations. Specifically, we first analyzed UCHL1 expression and its prognostic significance in glioma using the GEO2R, GEPIA2, and CGGA databases. Radiosensitivity, DNA repair capability, and GSC stemness were evaluated using clonogenic survival, comet, sphere formation, extreme limiting dilution assay, and Western blot analyses. To identify UCHL1–interacting proteins, co-immunoprecipitation coupled with mass spectrometry was performed, followed by deubiquitination and rescue experiments to validate its substrates and functional dependence. Our results revealed that UCHL1 was markedly overexpressed in radioresistant glioblastoma cells and glioma tissues, and its expression levels positively correlated with poor prognosis in patients with glioma. UCHL1 knockdown attenuated the sphere-forming capacity and self–renewal frequency of GSCs and impaired the cellular response to DNA damage following irradiation, thereby attenuating the radioresistant phenotype. Mechanistically, UCHL1 stabilizes keratin 18 (KRT18) protein via deubiquitination. The effects of UCHL1 on radioresistance and stemness properties were largely diminished upon KRT18 knockdown, accompanied by reduced expression of the stemness marker SOX2. Furthermore, KRT18 knockdown attenuated the radioresistant phenotype induced by UCHL1 overexpression. Collectively, these findings suggest a mechanistic axis through which UCHL1 may regulate GSC stemness and radioresistance and identify UCHL1 as a candidate therapeutic target for reversing therapeutic resistance in glioma, warranting further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Children's Hospital of Soochow University, Suzhou 215025, China.
- College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.
- Department of Pathology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School of Nanjing Medical University, Suzhou 215001, China.
- Department of Pharmacy, Medical Science and Technology Innovation Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School of Nanjing Medical University, Suzhou 215001…
- Department of Surgical Oncology, Children's Hospital of Soochow University, Suzhou 215025, China.
ORCID-Profile: Xinyuan Ding, Huiling Zhang, Wenjuan Wang
Förderung
- National Natural Science Foundation of China
- Suzhou Municipal Health Commission
- Jiangsu Province Key Laboratory of Anesthesiology
- Suzhou Science and Technology Bureau
- Jiangsu Pharmaceutical Association
- Science and Technology Development Fund
- Nanjing Medical University
- Jiangsu Key Laboratory of Neuropsychiatric Diseases
Zitieren
APA
Wang, H., Zheng, R., Liu, Q., Ding, X., Zhao, Y., Xu, J., Tang, R., Chen, L., Chen, X., Shi, H., Zhang, H., & Wang, W. (2026). The Deubiquitinating Enzyme UCHL1 Promotes Radiotherapy Resistance in Glioma by Stabilizing Keratin 18. International Journal of Molecular Sciences, 27(21), 9875. https://doi.org/10.3390/ijms27219875
Vancouver
Wang H, Zheng R, Liu Q, Ding X, Zhao Y, Xu J, et al. The Deubiquitinating Enzyme UCHL1 Promotes Radiotherapy Resistance in Glioma by Stabilizing Keratin 18. International Journal of Molecular Sciences. 2026;27(21):9875. doi:10.3390/ijms27219875
BibTeX
@article{Wang2026,
author = {Wang, Hanlu and Zheng, Rujuan and Liu, Qian and Ding, Xinyuan and Zhao, Ying and Xu, Jianyu and Tang, Ruze and Chen, Lulu and Chen, Xi and Shi, Hui and Zhang, Huiling and Wang, Wenjuan},
title = {The Deubiquitinating Enzyme UCHL1 Promotes Radiotherapy Resistance in Glioma by Stabilizing Keratin 18},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9875},
doi = {10.3390/ijms27219875}
}
EUVIMED